Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway.
about
Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporterABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-IThe ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier diseaseMolecular interactions between apoE and ABCA1: impact on apoE lipidationDecreased lipid efflux and increased susceptibility to cholesterol-induced apoptosis in macrophages lacking phosphatidylcholine transfer proteinHDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disordersNovel concepts in HDL pharmacology.HDL as a drug and nucleic acid delivery vehicleSerum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinasesNovel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In VitroTransbilayer phospholipid movements in ABCA1-deficient cells.Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2)The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A.Comparison of serum apolipoprotein A-I between Chinese multiple sclerosis and other related autoimmune diseaseSurface charge- and space-dependent transport of proteins in crowded environments of nanotailored posts.5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewHigh-density lipoprotein and atherosclerosis: Roles of lipid transporters.5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthmaCrystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases.ATP binding cassette G1-dependent cholesterol efflux during inflammation.A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in miceApolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux.Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.Cellular Localization and Trafficking of the Human ABCG1 TransporterThe Human ABCG1 Transporter Mobilizes Plasma Membrane and Late Endosomal Non-Sphingomyelin-Associated-Cholesterol for Efflux and Esterification.An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice.A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout miceAcrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.High density lipoprotein structure-function and role in reverse cholesterol transport.Regulation of ABCA1 functions by signaling pathwaysHelix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter.Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels.Apolipoprotein mimetic peptides: a new approach for the treatment of asthma.ApoA-1 mimetic restores adiponectin expression and insulin sensitivity independent of changes in body weight in female obese mice.
P2860
Q24302387-6A68DFAA-BEC8-432E-A41E-8FF6276ED4B5Q24303897-4BFA75EF-1FE5-4D8B-99A5-8850D7B6C99AQ24306475-6F84224D-179C-4CF8-8876-EDBBB095130EQ24306797-C6A48281-671A-41C0-9CB4-49893A3898BEQ24535065-4D86CDCA-6C15-4158-95B2-BE4B5B798AF5Q27691344-9BABB421-390A-4792-B83C-BE8817E3B4ABQ27692691-80D3DBC7-D06A-4FF3-8366-BF13A3FA18DAQ28083209-B47F144C-49D2-4F0F-A19F-D3B97E23FADCQ28296257-07BACF72-550A-413B-8A9B-0A9A62A61E75Q28546760-A4A295AA-BF84-4B4D-86AB-CB03684E6907Q33294704-6F3F25BE-2747-47E6-8E5E-92A96636215BQ33618352-66B448D6-C132-49F0-AC11-3696A8C50C46Q33687423-DA85EE48-528B-4103-9D99-DAC1EFA80D4CQ33745289-0276DF8F-E51B-4FF5-A830-E27ADBF092F3Q33813394-2ACCD182-6684-49E8-AFC6-DE7D6BA23BEEQ33941850-55120FD9-351B-496D-8038-08782F1FB9FBQ34035255-C710312A-CF6F-4985-9F40-264F9E38CC8DQ34144449-4EFF30E6-7F9E-45BE-8C0A-1A31E692B332Q34181607-77E0582E-B8ED-4F8E-80C1-2FB3D16A548CQ34238630-CDCF5C19-29B2-4CA6-BCE8-8066788D3184Q34404454-2E7EA0C6-3E93-4778-B715-46152327ADD6Q34449116-9E933FAC-95D6-48E9-B5D8-70D211355E26Q34478920-A8BAAC40-2AC5-4629-9054-EB9D90E1BCDCQ34503409-40492ACF-7A63-4014-BEDC-29A2561A0187Q34559952-B338FDF1-A682-4741-9D14-EC8529E8610EQ34594140-59E9EB3F-79A1-4F21-9D9A-CF1A44E5DF2EQ34655812-B9AF0F2E-6FF2-44FE-AC48-8F5ED31D69DBQ34781496-8ECCEA04-D248-46CE-8A57-AFB67961642CQ34792398-669B2C27-F2CA-4B9E-B760-4F95F4D0AC2EQ34792427-5E0A9603-5042-4C3B-99C7-7766E7A0D733Q34851167-F1C32185-6073-4E37-BB07-60BC297DA111Q34946523-BBE2B306-5B12-4943-8885-1B331D68CE3EQ35064519-34B1C397-23DA-49FF-9625-CF964489F727Q35539166-67DDD946-31BD-4634-ADDB-67C66FEC2393Q35547011-F8D2B608-A677-4344-97F1-010C942B589BQ35626943-654E1F7F-B3F2-4A3D-9D3D-CD540ECB75C2Q35660283-9DC700C1-09BF-434B-BCC1-8E0860C62BF7Q35694025-C274B233-9D71-46AD-BEE1-774DF33503F5Q35815986-F5CE9C26-CAE7-4559-9185-B648A47F7E06Q35926657-1479CA2A-E14A-4135-9BD4-08CE29474D3F
P2860
Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Synthetic amphipathic helical ...... an ABCA1-independent pathway.
@en
Synthetic amphipathic helical ...... an ABCA1-independent pathway.
@nl
type
label
Synthetic amphipathic helical ...... an ABCA1-independent pathway.
@en
Synthetic amphipathic helical ...... an ABCA1-independent pathway.
@nl
prefLabel
Synthetic amphipathic helical ...... an ABCA1-independent pathway.
@en
Synthetic amphipathic helical ...... an ABCA1-independent pathway.
@nl
P2093
P2860
P1476
Synthetic amphipathic helical ...... an ABCA1-independent pathway.
@en
P2093
Alan T Remaley
Alexander V Bocharov
Amy P Patterson
Edward B Neufeld
Fairwell Thomas
H Bryan Brewer
John A Stonik
Samantha E Bark
Silvia Santamarina-Fojo
Steve J Demosky
P2860
P304
P356
10.1194/JLR.M200475-JLR200
P577
2003-01-16T00:00:00Z